These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9704486)

  • 21. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
    Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
    J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells.
    Ragnarsson L; Strömberg T; Wijdenes J; Tötterman TH; Weigelt C
    Cancer Immunol Immunother; 2001 Sep; 50(7):382-90. PubMed ID: 11676398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and bioactivity analysis of Staphylococcal enterotoxin M and N.
    Pan YQ; Ding D; Li DX; Chen SQ
    Protein Expr Purif; 2007 Dec; 56(2):286-92. PubMed ID: 17910920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
    Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically engineered superantigens as tolerable antitumor agents.
    Hansson J; Ohlsson L; Persson R; Andersson G; Ilbäck NG; Litton MJ; Kalland T; Dohlsten M
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2489-94. PubMed ID: 9122222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma.
    Nielsen SE; Zeuthen J; Lund B; Persson B; Alenfall J; Hansen HH
    J Immunother; 2000 Jan; 23(1):146-53. PubMed ID: 10687147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.
    Alouf JE; Müller-Alouf H
    Int J Med Microbiol; 2003 Feb; 292(7-8):429-40. PubMed ID: 12635926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell cytotoxicity assays for studying the functional interaction between the superantigen staphylococcal enterotoxin A and T-cell receptors.
    Rosendahl A; Kristensson K; Riesbeck K; Dohlsten M
    Methods Mol Biol; 2000; 145():241-57. PubMed ID: 10820726
    [No Abstract]   [Full Text] [Related]  

  • 30. Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model.
    Sundstedt A; Celander M; Eriksson H; Törngren M; Hedlund G
    J Immunother; 2012 May; 35(4):344-53. PubMed ID: 22495392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens.
    Kieke MC; Sundberg E; Shusta EV; Mariuzza RA; Wittrup KD; Kranz DM
    J Mol Biol; 2001 Apr; 307(5):1305-15. PubMed ID: 11292343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia.
    Lorentzen CL; Straten PT
    Scand J Immunol; 2015 Oct; 82(4):307-19. PubMed ID: 26099639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superantigens Modulate Bacterial Density during Staphylococcus aureus Nasal Colonization.
    Xu SX; Kasper KJ; Zeppa JJ; McCormick JK
    Toxins (Basel); 2015 May; 7(5):1821-36. PubMed ID: 26008236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a putative B cell superantigen on complement.
    Kozlowski LM; Lambris JD; Levinson AI
    Ann N Y Acad Sci; 1995 Sep; 764():356-8. PubMed ID: 7486545
    [No Abstract]   [Full Text] [Related]  

  • 36. Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens.
    Rosendahl A; Kristensson K; Hansson J; Riesbeck K; Kalland T; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5309-13. PubMed ID: 9605129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
    Okamoto S; Kawabata S; Nakagawa I; Hamada S
    Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
    Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
    Sundstedt A; Grundström S; Dohlsten M
    Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.